Search Results - Xia Sheng

Hypertensive Retinopathy Secondary to Anlotinib Treatment by Xiaohua Zhang, Li Peng, Qing Xie, Qingjing Wu, Xia Sheng

Connect to this object online.

A Pan-Cancer Analysis of the Role of PBRM1 in Human Tumors by Jin Liu, Xiaoli Xie, Min Xue, Jianqing Wang, Qian Chen, Zhen Zhao, Xia Sheng

Connect to this object online.

Retraction Note: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and T... by Cheng Liu, Xia Yuan, Le Tao, Zhuoan Cheng, Xiuqin Dai, Xia Sheng, Dongying Xue

Connect to this object online.

In silico off-target profiling for enhanced drug safety assessment by Jin Liu, Yike Gui, Jingxin Rao, Jingjing Sun, Gang Wang, Qun Ren, Ning Qu, Buying Niu, Zhiyi Chen, Xia Sheng, Yitian Wang, Mingyue Zheng, Xutong Li

Connect to this object online.

Serious Workplace Violence Against Healthcare Providers in China Between 2004 and 2018 by Jing Ma, Xi Chen, Qiongjuan Zheng, Yun Zhang, Zhi Ming, Dongxin Wang, Hua Wu, Haisen Ye, Xiaoxuan Zhou, Yunxuan Xu, Renjiao Li, Xia Sheng, Fangxiu Fan, Zuiwen Yang, Ting Luo, Yajun Lu, Ye Deng, Fen Yang, Chuntao Liu, Chunyu Liu, Xiaosong Li

Connect to this object online.

Anticarin-β shows a promising anti-osteosarcoma effect by specifically inhibiting CCT4 to impair proteostasis by Gan Wang, Min Zhang, Ping Meng, Chengbo Long, Xiaodong Luo, Xingwei Yang, Yunfei Wang, Zhiye Zhang, James Mwangi, Peter Muiruri Kamau, Zhi Dai, Zunfu Ke, Yi Zhang, Wenlin Chen, Xudong Zhao, Fei Ge, Qiumin Lv, Mingqiang Rong, Dongsheng Li, Yang Jin, Xia Sheng, Ren Lai

Connect to this object online.